《新股消息》螞蟻集團董事名單曝光
據內地傳媒報道,證監會浙江監管局網站披露,中金公司、中信建投均已完成對螞蟻集團的上市輔導,螞蟻集團披露了最新的「高級管理人員備案」事項:阿里巴巴集團(09988.HK)合夥人彭蕾、阿里巴巴集團董事會主席兼首席執行官張勇、阿里巴巴首席財務官武衛退出董事,新增程立、蔣芳、胡祖六、黃益平、郝荃五人為董事。
新增董事中,程立為阿里巴巴集團首席技術官,蔣芳為阿里巴巴集團首席人才官。另三位新增董事則來自阿里巴巴集團外部,黃益平為北京大學國家發展研究院副院長,胡祖六為春華資本集團主席,郝荃或為知名會計師事務所畢馬威前合夥人。目前,螞蟻集團的董事長為井賢棟,首席執行官為胡曉明。(el/u) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.